MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202527121719 A) filed by Jiangsu Hengrui Pharmaceuticals Co. , Ltd.; and Shanghai Hengrui Pharmaceutical Co. , Ltd. on December 04, 2025, for Anti-Npr1 Antibody And Pharmaceutical Use Thereof.
Inventors include Ying, Hanxiao; Shi, Jinping; Xu, Yingxia; Jin, Xinsheng; and Li, Xun.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: Provided are an anti-NPR1 antibody, a pharmaceutical composition comprising the antibody, and an immunoconjugate. Also provided are an isolated nucleic acid encoding the NPR1 antibody, a host cell comprising the isolated nucleic acid, a method for using the NPR1 antibody ...